Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06536946

B-catenin in Cutaneous Squamous Cell Carcinoma and Its Mimickers

Expression of B-catenin in Cutaneous Squamous Cell Carcinoma and Its Mimickers

Status
Recruiting
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
Sohag University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Examine the role of B-catenin in differentiation of cutaneous squamous cell carcinoma from other lesions that may be similar to it

Detailed description

Skin cancer is one of the most common form of cancer worldwide. Cutaneous squamous cell carcinoma is one of most common skin tumers that caused by many factors as ultra violet ,ionizing radiation and others . It was an advanced spectrum ranging from actinic keratosis to invasive and metastatic squmous cell carcinoma. Correct identification of cutaneous squamous cell carcinoma is a challenge as it has both clinically and histopathologically mimickers. So the aim of this study is to identify the expression of B-catenin in cutaneous Squamous cell carcinoma and its mimickers.

Conditions

Interventions

TypeNameDescription
BIOLOGICALImmunohistochemical stainingStaining of cutanous squamous cell carcinoma and its mimickers by monoclonal antibodies against human B-catenin by immunohistochemical procedures

Timeline

Start date
2024-06-01
Primary completion
2024-12-30
Completion
2025-09-30
First posted
2024-08-05
Last updated
2024-08-06

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06536946. Inclusion in this directory is not an endorsement.